NGM BIOPHARMACEUTICALS INC (22) | Uncategorized (6)

Recent Contracts

Amendment No. 9 on November (Filed With SEC on March 1, 2022)
Offer Letter Agreement, by and between the Registrant and Hsiao D. Lieu, M.D., dated as of January 16, 2019 (Filed With SEC on May 6, 2021)
Offer Letter Agreement, by and between the Registrant and Valerie L. Pierce, dated as of August 6, 2019, and related information (Filed With SEC on May 6, 2021)
Letter Agreement, dated as of March 12, 2021, by and between Merck Sharp & Dohme Corp. and NGM Biopharmaceuticals, Inc (Filed With SEC on March 15, 2021)
Offer Letter Agreement, by and between the Registrant and Siobhan Nolan Mangini, dated as of May 20, 2020 (Filed With SEC on August 12, 2020)
Letter Agreement, by and between NGM Biopharmaceuticals, Inc. and Merck Sharp & Dohme Corp., dated as of March 15, 2019 (Filed With SEC on March 25, 2019)